Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide
Cj. Fowler et al., Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide, BIOCH PHARM, 62(5), 2001, pp. 517-526
Fatty acid amide hydrolase (FAAH) is responsible for the hydrolysis of a nu
mber of important endogenous fatty acid amides, including the endogenous ca
nnabimimetic agent anandamide (AEA), the sleep-inducing compound oleamide,
and the putative anti-inflammatory agent palmitoylethanolamide (PEA). In re
cent years, there have been great advances in our understanding of the bioc
hemical and pharmacological properties of the enzyme. In this commentary, t
he structure and biochemical properties of FAAH and the development of pote
nt and selective FAAH inhibitors are reviewed, together with a brief discus
sion on the therapeutic possibilities for such compounds in the treatment o
f inflammatory pain and ischaemic states. (C) 2001 Elsevier Science Inc. Al
l rights reserved.